Continuous renal replacement therapy (CRRT) attenuates myocardial inflammation and mitochondrial injury induced by venovenous extracorporeal membrane oxygenation (VV ECMO) in a healthy piglet model

Inflammation

Volumn 36, Issue 5, 2013, Pages 1186-1193

  Shen, Juanhong ^a   Yu, Wenkui ^a   Chen, Qiyi ^a   Shi, Jialiang ^a   Hu, Yimin ^a   Zhang, Juanjuan ^a   Gao, Tao ^a   Xi, Fengchan ^a   He, Changsheng ^a   Gong, Jianfeng ^a   Li, Ning ^a   Li, Jieshou ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

Author keywords

continuous renal replacement therapy (CRRT); mitochondrial function; myocardial inflammation; venovenous extracorporeal membrane oxygenation (VV ECMO)

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MITOCHONDRIAL COMPLEX IV; MITOCHONDRIAL COMPLEX V; MITOCHONDRIAL ENZYME; MYELOPEROXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); SUCCINATE DEHYDROGENASE (UBIQUINONE); TUMOR NECROSIS FACTOR ALPHA; UBIQUINOL CYTOCHROME C REDUCTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME ACTIVITY; EXTRACORPOREAL OXYGENATION; FEMALE; GENE EXPRESSION; INFLAMMATION; MALE; MITOCHONDRION DAMAGE; MYOCARDITIS; NONHUMAN; PIGLET; PROTEIN BLOOD LEVEL; THERAPY EFFECT; TISSUE LEVEL; VENOVENOUS EXTRACORPOREAL MEMBRANE OXYGENATION;

ANIMALS; CARDIOMYOPATHIES; ELECTRON TRANSPORT COMPLEX I; ELECTRON TRANSPORT COMPLEX IV; EXTRACORPOREAL MEMBRANE OXYGENATION; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; MITOCHONDRIA; MYOCARDIUM; PEROXIDASE; RENAL REPLACEMENT THERAPY; RNA, MESSENGER; SWINE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84885175798     PISSN: 03603997     EISSN: 15732576     Source Type: Journal    
DOI: 10.1007/s10753-013-9654-7     Document Type: Article

References (35)

1. MacLaren, G., A. Combes, and R.H. Bartlett. 2012. Contemporary extracorporeal membrane oxygenation for adult respiratory failure: life support in the new era. Intensive Care Medicine 38: 210-220.
2. Tiruvoipati, R., J. Botha, and G. Peek. 2012. Effectiveness of extracorporeal membrane oxygenation when conventional ventilation fails: valuable option or vague remedy? Journal of Critical Care 27: 192-198.
3. Peek, G.J., M. Mugford, R. Tiruvoipati, A. Wilson, E. Allen, M.M. Thalanany, et al. 2009. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. The Lancet 374: 1351-1363.
4. Noah, M.A., G.J. Peek, S.J. Finney, M.J. Griffiths, D.A. Harrison, R. Grieve, et al. 2011. Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). JAMA: The Journal of the American Medical Association 306: 1659-1668.
5. Schmid, C., A. Philipp, M. Hilker, L. Rupprecht, M. Arlt, A. Keyser, et al. 2012. Venovenous extracorporeal membrane oxygenation for acute lung failure in adults. The Journal of Heart and Lung Transplantation 31: 9-15.
6. Brogan, T.V., R.R. Thiagarajan, P.T. Rycus, R.H. Bartlett, and S.L. Bratton. 2009. Extracorporeal membrane oxygenation in adults with severe respiratory failure: a multi-center database. Intensive Care Medicine 35: 2105-2114.
7. Nehra, D., A.M. Goldstein, D.P. Doody, D.P. Ryan, Y. Chang, and P.T. Masiakos. 2009. Extracorporeal membrane oxygenation for nonneonatal acute respiratory failure: the Massachusetts General Hospital experience from 1990 to 2008. Archives of Surgery 144: 427-432.
8. Steinhorn, R.H., B. Isham-Schopf, C. Smith, and T.P. Green. 1989. Hemolysis during long-term extracorporeal membrane oxygenation. The Journal of Pediatrics 115: 625-630.
9. Kurundkar, A.R., C.R. Killingsworth, R.B. McIlwain, J.G. Timpa, Y.E. Hartman, D. He, et al. 2010. Extracorporeal membrane oxygenation causes loss of intestinal epithelial barrier in the newborn piglet. Pediatric Research 68: 128-133.
10. Adrian, K., K. Mellgren, M. Skogby, L.G. Friberg, G. Mellgren, and H. Wadenvik. 1998. Cytokine release during long-term extracorporeal circulation in an experimental model. Artificial Organs 22: 859-863.
11. Fortenberry, J.D., V. Bhardwaj, P. Niemer, J.D. Cornish, J.A. Wright, and L. Bland. 1996. Neutrophil and cytokine activation with neonatal extracorporeal membrane oxygenation. The Journal of Pediatrics 128: 670-678.
12. McILwain, B., T. Joseph, A.R. Kurundkar, D.W. Holt, D.R. Kelly, and Y. Hartman. 2010. Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of pre-formed stores in the intestine. Laboratory Investigation 1: 128-139.
13. Zanotti-Cavazzoni, S.L., and S.M. Hollenberg. 2009. Cardiac dysfunction in severe sepsis and septic shock. Current Opinion in Critical Care 15: 392-397.
14. Ventura-Clapier, R., A. Garnier, and V. Veksler. 2004. Energy metabolism in heart failure. The Journal of Physiology 555: 1-13.
15. Matsuda, K., H. Hirasawa, S. Oda, H. Shiga, and K. Nakanishi. 2001. Current topics on cytokine removal technologies. Therapeutic Apheresis 5: 306-314.
16. Schetz M. 1999. Non-renal indications for continuous renal replacement therapy. Kidney International. Supplement 72:S88-94.
17. De Vriese, A.S., R.C. Vanholder, M. Pascual, N.H. Lameire, and F.A. Colardyn. 1999. Can inflammatory cytokines be removed efficiently by continuous renal replacement therapies? Intensive Care Medicine 25: 903-910.
18. Skogby, M., K. Adrian, L.G. Friberg, G. Mellgren, and K. Mellgren. 2000. Influence of hemofiltration on plasma cytokine levels and platelet activation during extra corporeal membrane oxygenation. Scandinavian Cardiovascular Journal 34: 315-320.
19. Mu, T.S., E.G. Palmer, S.G. Batts, S.L. Lentz-Kapua, J.H. Uyehara-Lock, and C.F. Uyehara. 2012. Continuous renal replacement therapy to reduce inflammation in a piglet hemorrhage-reperfusion extracorporeal membrane oxygenation model. Pediatric Research 72: 249-255.
20. Naran, N., M. Sagy, and K.R. Bock. 2010. Continuous renal replacement therapy results in respiratory and hemodynamic beneficial effects in pediatric patients with severe systemic inflammatory response syndrome and multiorgan system dysfunction. Pediatric Critical Care Medicine 11: 737-740.
21. Ishihara, S., J.A. Ward, O. Tasaki, B.J. Pruitt, and D.W. Mozingo. 2009. Cardiac contractility during hemofiltration in an awake model of hyperdynamic endotoxemia. The Journal of Trauma 67: 1055-1061.
22. Li, C.M., J.H. Chen, P. Zhang, Q. He, J. Yuan, R.J. Chen, et al. 2007. Continuous veno-venous haemofiltration attenuates myocardial mitochondrial respiratory chain complexes activity in porcine septic shock. Anaesthesia and Intensive Care 35: 911-919.
23. Bradford, M.M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 72: 248-254.
24. Poderoso, J.J., M.C. Carreras, C. Lisdero, N. Riobo, F. Schopfer, and A. Boveris. 1996. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria and submitochondrial particles. Archives of Biochemistry and Biophysics 328: 85-92.
25. Sudheesh, N.P., T.A. Ajith, and K.K. Janardhanan. 2009. Ganoderma lucidum (Fr.) P. Karst enhances activities of heart mitochondrial enzymes and respiratory chain complexes in the aged rat. Biogerontology 10: 627-636.
26. Bedard, P.M., B. Zweiman, and P.C. Atkins. 1983. Quantitation by myeloperoxidase assay of neutrophil accumulation at the site of in vivo allergic reactions. Journal of Clinical Immunology 3: 84-89.
27. Wan, S., J.M. DeSmet, L. Barvais, M. Goldstein, J.L. Vincent, and J.L. LeClerc. 1996. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. The Journal of Thoracic and Cardiovascular Surgery 112: 806-811.
28. Galley, H.F. 2011. Oxidative stress and mitochondrial dysfunction in sepsis. British Journal of Anaesthesia 107: 57-64.
29. Rudiger, A., and M. Singer. 2007. Mechanisms of sepsis-induced cardiac dysfunction. Critical Care Medicine 35: 1599-1608.
30. Zimmerman, G.A., A.H. Morris, and M. Cengiz. 1982. Cardiovascular alterations in the adult respiratory distress syndrome. The American Journal of Medicine 73: 25-34.
31. Bajwa, E.K., P.D. Boyce, J.L. Januzzi, M.N. Gong, B.T. Thompson, and D.C. Christiani. 2007. Biomarker evidence of myocardial cell injury is associated with mortality in acute respiratory distress syndrome. Critical Care Medicine 35: 2484-2490.
32. Askenazi, D.J., D.T. Selewski, M.L. Paden, D.S. Cooper, B.C. Bridges, M. Zappitelli, et al. 2012. Renal replacement therapy in critically ill patients receiving extracorporeal membrane oxygenation. Clinical Journal of the American Society of Nephrology 7: 1328-1336.
33. Smith, A.H., D.C. Hardison, C.R. Worden, G.M. Fleming, and M.B. Taylor. 2009. Acute renal failure during extracorporeal support in the pediatric cardiac patient. ASAIO Journal 55: 412-416.
34. Hirasawa, H. 2010. Indications for blood purification in critical care. Contributions to Nephrology 166: 21-30.
35. Honore, P.M., O. Joannes-Boyau, W. Boer, and V. Collin. 2009. High-volume hemofiltration in sepsis and SIRS: current concepts and future prospects. Blood Purification 28: 1-11.